Contents:

NEUROSTIMULATION A GLOBAL STRATEGIC BUSINESS REPORT CONTENTS 1. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS 1 Study Reliability and Reporting Limitations 1 Disclaimers 2 Data Interpretation & Reporting Level 3 Quantitative Techniques & Analytics 3 Product Definitions and Scope of Study 3 Spinal Cord Stimulation (SCS) 4 Radio Frequency (RF) Systems 4 Implantable Pulse Generator Systems (IPGs) 4 Deep Brain Stimulation (DBS) 4 Sacral Nerve Stimulation (SNS) 4 Vagus Nerve Stimulation (VNS) 5 2. MARKET SNAPSHOTS 6 3. MARKET OVERVIEW 7 Rising Demand for Neurostimulation Devices 7 Current and Future Analysis 8 Table 1: Worldwide Neurostimulation Market (2007-2015): Product Segments (Spinal Cord Stimulators, Deep Brain Stimulators, Sacral Nerve Stimulators, and Vagus Nerve Stimulators) Ranked by Growth (includes corresponding Graph/Chart) 9 Neurostimulation Therapy Gets Popular 9 Technological Advancements So Far 10 SCS - The New Painkiller 10 Future Prospects 10 Obesity Control to Spur Market Growth in Future 11 4. TRENDS AND ISSUES 12 Chip Makers Struggle to Meet Quality Demand 12 Market Growth Attracts New Investors 12 Neurostimulation on a Rise with Growing Indications 12 Neurostimulation Market Marked by High Entry Barriers 12 Increasing Acceptance of Neurostimulation due to Advanced Clinical Benefits 13 Powering Neurostimulation Devices-The Key to Success 13 Market Development Initiatives to Fuel Market Growth 14 Exploring Market Opportunities - The Technology Way 14 Neurostimulation Devices - Growing Awareness and Acceptance Among Physicians 14 Synergy with Pharma & Biotech Companies Creates New Avenues 15 Third-Party Reimbursement - A Vital Role to Play 15 5. COMPETITIVE SCENARIO 16 Few Players Dominate Neurostimulation Market 16 Worldwide Neurostimulation Market: Leading Players by Product Segment 16 Table 2: Leading Players in the Global Neurostimulation Market (2009E): Percentage Share Breakdown of Value Sales for Medtronic, St. Jude Medical, Boston Scientific, Cyberonics and Others (includes corresponding Graph/Chart) 17 Table 3: World Neurostimulation Market (2009): Percentage Share Breakdown of Value Sales for Pain, Deafness, Epilepsy, Movement Disorders, Depression, Stroke, Incontinence, Gastroparesis and Obesity (includes corresponding Graph/Chart) 17 Product Offerings of Leading Players in the Neurostimulation Market 18 Select Spinal Cord Stimulation Product Offerings of St. Jude and Medtronic 18 Stimulation Parameters of Select SCS Products 19 Companies Researching Neurostimulator Applications by Indication 19 6. NEUROMODULATION INDUSTRY: AN INSIGHT 20 Attacking the Source of Pain - The Logic behind Neuromodulation 20 Growth Prospects for Neuromodulation Industry 20 7. PRODUCT OVERVIEW 22 Introduction to Neurostimulator 22 A Historical Note 22 Neurostimulation Devices by Product Segment 23 Spinal Cord Stimulation (SCS) 23 SCS - What it Treats 24 Segmentation by Type of Power Source 24 Implantable Pulse Generator Systems (IPGs) 24 Radio Frequency (RF) Systems 25 Market Assessment for RF Systems 25 Sacral Nerve Stimulation (SNS) 25 Deep Brain Stimulation (DBS) 26 Vagus Nerve Stimulation (VNS) 26 Gastric Electric Stimulation (GES) 27 Stimulation Device - How it Works 27 Neurostimulation & its Benefits 28 Prospective Application Areas for Neurostimulators - Select Indications 28 Neurostimulation Indications and Use of Related Devices/ Techniques in the US 29 Approved Indications for Spinal Cord Stimulation by Geographic Regions 29 Neurostimulation Devices - Technology & Safety Issues 30 8. RECENT INDUSTRY ACTIVITY 31 Sonova Holding Acquires Advanced Bionics 31 NeuroMetrix Purchases Select Assets of Cyberkinetics Neurotechnology Systems 31 St. Jude Medical Purchases Non-Cash Assets and Intellectual Property of Northstar Neuroscience 31 Victhom Human Bionics Signs Agreement with Otto Bock HealthCare 32 Neuros Medical Collaborates with Battelle 32 JumpStart & CTV Invest in Neuros Medical 32 InterWest Invests in Autonomic Technologies 33 MicroTransponder Finalizes Series A Funding Round for Wireless Neurostimulator Development 33 NDI Medical Divests MEDSTIM Device to Medtronic 33 Cyberkinetics Neurotechnology Systems and NeuroMetrix Enters into Joint Venture Agreement 34 Greatbatch Takes Over Quan Emerteq 34 RS Medical Takes Over CFS Medical 34 Cyberkinetics and Neurometrix Form Joint Venture to Develop Andara™ OFS™ 35 St. Jude Bags CE Mark and FDA Approvals for Eon Mini™ 35 St. Jude Medical Initiates Clinical Study of DBS 35 ANS Bags CE Mark Approval for Rapid Programmer 3.0 36 Northstar Completes Trial of Renova-ST™ 36 Greatbatch Acquires Enpath Medical 36 Critical Therapeutics Grants Global License to Innovative Metabolics 36 Biomet Merges with LVB Acquisition 37 US Patent and Trademark Office Issues Cyberkinetics Patent for Andara™OFS™ Therapy 37 Cyberonics Licenses Obesity-Related Patents 37 Stryker Invests in Afferent Corp 38 Medtronic Receives PMA Approval for Specify™ 5-6-5 Surgical Lead 38 BioControl Initiates CardioFit™ System’s Trials 38 Medtronic Initiates Post-Market Study of InterStim™ 38 Cyberkinetics Successfully Tests Andara™OFS™ System 38 Medtronic Completes Implants in SANTE Trial of Deep Brain Stimulation 38 Cyberonics Receives US FDA Approval for Demipulse™ and Demipulse Duo™ 39 Cyberonics Signs Licensing Agreement with Ethicon Endo-Surgery 39 AMS Acquires Implantable Electrical Stimulation Platform Technology from BioControl 39 Medtronic Bags FDA Approval on Interstim® 39 Boston’s Precision SCS System Successfully Implanted 40 New Computer System to Improve Efficiency of Deep Brain Stimulation 40 Cyberonics Bags FDA Approval for VNS Therapy System Labeling Format 40 Impulse Dynamics Sponsors Study to Evaluate Optimizer 40 Medtronic to Pursue Major Clinical Trial of DBS 40 Cyberonics Bags FDA Real-Time Review Approval for Perennia™ Lead 40 Northstar Chooses AMI Semiconductor 41 American Medical Acquires Technology License from BioControl Medical 41 American Medical Systems Holdings Takes Over the Urology Unit of MedImpulse 41 Cyberkinetics Acquires Andara 42 Cyberkinetics Pacts with Minnetronix 42 Symphony Medical Strikes Deal with NDI Medical 42 NDI Opens New Business Unit 42 BRCP Funds Case to Extend Research Capabilities of ONNP 42 ANS Receives Clearance on Eon for European Market 42 Medtronic Receives FDA Nod for RestorePRIME 43 Boston Scientific Implants PRISM 43 Neuroscience Bags FDA Approval on P-Stim™ 43 Victhom Receives Patents from USPTO 43 9. PRODUCT INNOVATIONS/INTRODUCTIONS 44 Medtronic Unveils Brain Stimulation Products 44 Alphalife Launches Alpha Brainwave Neurostimulator 44 ImThera Medical Introduces aura6000™ Neurostimulation System 44 St. Jude Receives Approval for Neurostimulation System from Japanese MHLW 44 St. Jude Secures European CE Mark Approval for Epiducer™ Lead Delivery System 45 St. Jude Medical Obtains TGA Approval for Brio™ DBS System 45 Boston Scientific Secures FDA Approval for D4 and W4 SCS Lead Splitters 45 Mobilis Healthcare Introduces InterX 46 IMEC Develops and Models New Design for Brain Stimulation Implants 46 St. Jude Medical Receives Approval for Penta Neurostimulation Lead from FDA 46 St. Jude Receives European CE Mark Approval for LibraXP™ and Libra® Deep Brain Stimulation Systems 47 Medtronic Receives FDA Approval for Activa PC and Activa RC DBS Devices 47 Medtronic Receives FDA Approval for Reclaim™ Deep Brain Stimulation Therapy 47 St. Jude Receives European CE Mark Approval for Genesis® Neurostimulation System 47 St. Jude Eon Mini™ Neurostimulator Receives Australian Therapeutic Goods Administration Approval 48 Medtronic Receives FDA Approval for Activa® RC, Activa PC DBS Devices 48 Medtronic Gains FDA Approval for RestoreULTRA™ Neurostimulator 49 St. Jude Receives European CE Mark and FDA Approval for EonC™ 49 St. Jude Receives Battery Longevity Approval from European CE Mark and FDA for Eon® 49 Medtronic Delivers Procedural Intelligence in StealthStation® System 50 Medtronic Unveils Patient Referral Advisor Software in US 50 Boston Scientific Introduces Smallest Rechargeable SCS System 50 Tennessee Inventors Develops Apparatus of Deep Brain Stimulator 51 California Inventors Develop IPG 51 Medtronic Rolls Out Two ImplanTable Neurostimulation Systems 51 Medtronic Introduces Two Latest Neurostimulation Systems 51 Neuroscience Therapy Launches P-Stim Electro Stimulation Device 52 NeuroPace and AMI Semiconductor Develops ImplanTableEpilepsy Device 52 Neuroscience Launches P-Stim™ 52 AMI Semiconductor to Develop ASIC for New Stroke Therapy 53 Medtronic Unveils Two New Neurostimulation Systems 53 ANS Launches Rapid Programmer 3.0 53 10. FOCUS ON SELECT PLAYERS 54 Afferent Corp. (USA) 54 Boston Scientific Corp. (USA) 54 Cyberkinetics Neurotechnology Systems, Inc. (USA) 54 Cyberonics, Inc. (USA) 55 Medtronic, Inc. (USA) 55 St. Jude Medical, Inc. (USA) 56 Synapse Biomedical, Inc. (USA) 56 11. GLOBAL MARKET PERSPECTIVE 57 Table 4: World Recent Past, Current & Future Analysis for Neurostimulation by Geographic Region - US and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for the Years 2007 through 2015 (includes corresponding Graph/Chart) 57 Table 5: World Historic Review for Neurostimulation by Geographic Region - US and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for the Years 2000 through 2006 (includes corresponding Graph/Chart) 58 Table 6: World 11-Year Perspective for Neurostimulation by Geographic Region - Percentage Breakdown of Value Sales for US and Rest of World Markets for the Years 2005, 2010 and 2015 58 Table 7: World Recent Past, Current & Future Analysis for Spinal Cord Stimulators by Geographic Region - US and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for the Years 2007 through 2015 (includes corresponding Graph/Chart) 59 Table 8: World Recent Past, Current & Future Analysis for Spinal Cord Stimulators by Product Segment - Radio Frequency (RF) System and Implantable Pulse Generator (IPG) Markets Independently Analyzed with Annual Sales Figures in US$ Million for the Years 2007 through 2015 (includes corresponding Graph/Chart) 59 Table 9: World Historic Review for Spinal Cord Stimulators by Geographic Region - US and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for the Years 2000 through 2006 (includes corresponding Graph/Chart) 60 Table 10: World Historic Review for Spinal Cord Stimulators by Product Segment - Radio Frequency (RF) System and Implantable Pulse Generator (IPG) Markets Independently Analyzed with Annual Sales Figures in US$ Million for the Years 2000 through 2006 (includes corresponding Graph/Chart) 60 Table 11: World 11-Year Perspective for Spinal Cord Stimulators by Geographic Region - Percentage Breakdown of Value Sales for United States and Rest of the World Markets for the Years 2005, 2010 and 2015 61 Table 12: World 11-Year Perspective for Spinal Cord Stimulators by Product Segment - Percentage Breakdown of Value Sales for Radio Frequency (RF) System and Implantable Pulse Generator (IPG) Markets for the Years 2005, 2010 and 2015 61 Table 13: World Recent Past, Current & Future Analysis for Radio Frequency Spinal Cord Stimulators by Geographic Region - US and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for the Years 2007 through 2015 (includes corresponding Graph/Chart) 62 Table 14: World Historic Review for Radio Frequency Spinal Cord Stimulators by Geographic Region - US and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for the Years 2000 through 2006 (includes corresponding Graph/Chart) 62 Table 15: World 11-Year Perspective for Radio Frequency Spinal Cord Stimulators by Geographic Region - Percentage Breakdown of Value Sales for United States and Rest of the World Markets for the Years 2005, 2010 and 2015 63 Table 16: World Recent Past, Current & Future Analysis for Implantable Pulse Generator (IPG) Spinal Cord Stimulators by Geographic Region - US and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for the Years 2007 through 2015 (includes corresponding Graph/Chart) 64 Table 17: World Historic Review for Implantable Pulse Generator (IPG) Spinal Cord Stimulators by Geographic Region - US and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for the Years 2000 through 2006 (includes corresponding Graph/Chart) 64 Table 18: World 11-Year Perspective for Implantable Pulse Generator (IPG) Spinal Cord Stimulators by Geographic Region - Percentage Breakdown of Value Sales for US and Rest of World Markets for the Years 2005, 2010 and 2015 65 Table 19: World Recent Past, Current & Future Analysis for Deep Brain Stimulators by Geographic Region - US and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for the Years 2007 through 2015 (includes corresponding Graph/Chart) 66 Table 20: World Historic Review for Deep Brain Stimulators by Geographic Region - US and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for the Years 2000 through 2006 (includes corresponding Graph/Chart) 66 Table 21: World 11-Year Perspective for Deep Brain Stimulators by Geographic Region - Percentage Breakdown of Value Sales for United States and Rest of the World Markets for the Years 2005, 2010 and 2015 67 Table 22: World Recent Past, Current & Future Analysis for Sacral Nerve Stimulators by Geographic Region - US and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for the Years 2007 through 2015 (includes corresponding Graph/Chart) 68 Table 23: World Historic Review for Sacral Nerve Stimulators by Geographic Region - US and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for the Years 2000 through 2006 (includes corresponding Graph/Chart) 68 Table 24: World 11-Year Perspective for Sacral Nerve Stimulators by Geographic Region - Percentage Breakdown of Value Sales for United States and Rest of the World Markets for the Years 2005, 2010 and 2015 69 Table 25: World Recent Past, Current & Future Analysis for Vagus Nerve Stimulators by Geographic Region - US and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for the Years 2007 through 2015 (includes corresponding Graph/Chart) 70 Table 26: World Historic Review for Vagus Nerve Stimulators by Geographic Region - US and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for the Years 2000 through 2006 (includes corresponding Graph/Chart) 70 Table 27: World 11-Year Perspective for Vagus Nerve Stimulators by Geographic Region - Percentage Breakdown of Value Sales for United States and Rest of the World Markets for the Years 2005, 2010 and 2015 71 12. THE UNITED STATES 72 A.Market Analysis 72 Overview 72 Neurostimulation Products Market to Witness Growth 72 Product Segments Ranked by Growth 73 Table 28: Neurostimulation Market in the US (2007-2015): Product Segments (Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS) and Gastric Electric Stimulators (GES)) Ranked by Growth in Volume Sales (includes corresponding Graph/Chart) 73 Table 29: Neurostimulation Market in the US (2007-2015): Product Segments (SpinalCord Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS) and Gastric Electric Stimulators (GES)) Ranked by Growth in Value Sales (includes corresponding Graph/Chart) 74 Table 30: Neurostimulation Market in the US (2010): Unit Sales & Percentage Breakdown by Product Segment - Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS) and Gastric Electric Stimulators (GES) (includes corresponding Graph/Chart) 74 Table 31: Neurostimulation Market in the US (2010): Value Sales (in US$ Million) & Percentage Market Share by Product Segment - Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS) and Gastric Electric Stimulators (GES) (includes corresponding Graph/Chart) 75 Potential Growth for Neurostimulation Systems in the US 75 Spinal Cord Stimulation Products Market 75 Sacral Nerve Stimulation Products Market 76 Deep Brain Stimulation Products Market 77 Shift Away from Orthopaedic and Cardiovascular Device Markets 77 Trends in the Embolotherapy Market 78 Neurovascular Stents Market Attracting Cardiovascular Companies 78 Migraine Devices - New Frontiers for Neurostimulation 79 Competitive Landscape 79 Table 32: Leading Players in the US Neurostimulation Market (2009E): Percentage Breakdown of Revenues for Medtronic, Advanced Bionics, St. Jude Medical, Cyberonics and Others (includes corresponding Graph/Chart) 80 B.Market Analytics 80 Table 33: US Recent Past, Current & Future Analysis for Neurostimulators by Product Segment - Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS), and Gastric Electric Stimulators (GES) Markets Independently Analyzed with Annual Sales Figures in Units for Years 2007 through 2015 (includes corresponding Graph/Chart) 80 Table 34: US Recent Past, Current & Future Analysis for Neurostimulators by Product Segment - Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS), and Gastric Electric Stimulators (GES) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart) 81 Table 35: US Historic Review for Neurostimulators by Product Segment - Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS), and Gastric Electric Stimulators (GES) Markets Independently Analyzed with Annual Sales Figures in Units for Years 2000 through 2006 (includes corresponding Graph/Chart) 82 Table 36: US Historic Review for Neurostimulators by Product Segment - Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS), and Gastric Electric Stimulators (GES) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart) 83 Table 37: US 11-Year Perspective for Neurostimulators by Product Segment - Percentage Breakdown of Unit Sales for Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS), and Gastric Electric Stimulators (GES) Markets for the Years 2005, 2010 and 2015 (includes corresponding Graph/Chart) 84 Table 38: US 11-Year Perspective for Neurostimulators by Product Segment - Percentage Breakdown of Value Sales for Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS), and Gastric Electric Stimulators (GES) Markets for the Years 2005, 2010 and 2015 (includes corresponding Graph/Chart) 85 Table 39: US Recent Past, Current & Future Analysis for Spinal Cord Stimulators by Product Segment - Radio Frequency (RF) System and Implantable Pulse Generator (IPG) Markets Independently Analyzed with Annual Sales Figures in Units for Years 2007 through 2015 (includes corresponding Graph/Chart) 86 Table 40: US Recent Past, Current & Future Analysis for Spinal Cord Stimulators by Product Segment - Radio Frequency (RF) System and Implantable Pulse Generator (IPG) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart) 86 Table 41: US Historic Review for Spinal Cord Stimulators by Product Segment - Radio Frequency (RF) System and Implantable Pulse Generator (IPG) Markets Independently Analyzed with Annual Sales Figures in Units for Years 2000 through 2006 (includes corresponding Graph/Chart) 87 Table 42: US Historic Review for Spinal Cord Stimulators by Product Segment - Radio Frequency (RF) System and Implantable Pulse Generator (IPG) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart) 87 Table 43: US 11-Year Perspective for Spinal Cord Stimulators by Product Segment - Percentage Breakdown of Unit Sales for Radio Frequency (RF) System and Implantable Pulse Generator (IPG) Markets for the Years 2005, 2010 and 2015 88 Table 44: US 11-Year Perspective for Spinal Cord Stimulators by Product Segment - Percentage Breakdown of Value Sales for Radio Frequency (RF) System and Implantable Pulse Generator (IPG) Markets for the Years 2005, 2010 and 2015 88 13. REST OF WORLD 89 A.Market Analysis 89 Outlook 89 B.Market Analytics 89 Table 45: Rest of World Recent Past, Current & Future Analysis for Neurostimulators by Product Segment - Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS), and Gastric Electric Stimulators (GES) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart) 89 Table 46: Rest of World Historic Review for Neurostimulators by Product Segment - Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS), and Gastric Electric Stimulators (GES) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart) 90 Table 47: Rest of World 11-Year Perspective for Neurostimulators by Product Segment - Percentage Breakdown of Value Sales for Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS), and Gastric Electric Stimulators (GES) Markets for the Years 2005, 2010 and 2015 (includes corresponding Graph/Chart) 91 Table 48: Rest of World Recent Past, Current & Future Analysis for Spinal Cord Stimulators by Product Segment - Radio Frequency (RF) System and Implantable Pulse Generator (IPG) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart) 92 Table 49: Rest of World Historic Review for Spinal Cord Stimulators by Product Segment - Radio Frequency (RF) System and Implantable Pulse Generator (IPG) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart) 93 Table 50: Rest of World 11-Year Perspective for Spinal Cord Stimulators by Product Segment - Percentage Breakdown of Value Sales for Radio Frequency (RF) System and Implantable Pulse Generator (IPG) Markets for the Years 2005, 2010 and 2015 93 COMPETITIVE LANDSCAPE Total Companies Profiled: 29 (including Divisions/Subsidiaries - 33) --------- Region/Country Players --------- The United States 25 Canada 1 Europe 6 The United Kingdom 2 Rest of Europe 4 Asia-Pacific (Excluding Japan) 1 ---------

Companies Mentioned

The Companies Mentioned inside this report include: Advanced Neuromodulation Systems, Inc (USA) Afferent Corporation (USA) Axelgaard Mfg Co, Ltd (USA) Boston Scientific Corporation (USA) Advanced Bionics Corporation (USA) Chattanooga Group, Inc (USA) Cyberkinetics Neurotechnology Systems, Inc (USA) Cyberonics, Inc (USA) Cyberonics Europe SA (Belgium) Electro-Med Health Industries (USA) Electromedical Products International, Inc (USA) Electromedical Products International (Europe) Ltd Empi, Inc (USA) Medtronic, Inc (USA) Medtronic Ltd (UK) Medtronic (Schweiz) AG (Switzerland) Neurotech SA (Belgium) Northstar Neuroscience (USA) Synapse Biomedical Ltd (USA) Viamed Medical Products (UK)